CANNAPHARMARX, INC. Repayments of Convertible Debt
CANNAPHARMARX, INC. (CPMD) reported Repayments of Convertible Debt of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2025-11-14
- CANNAPHARMARX, INC. repayments of convertible debt for the quarter ending 2025-09-30 was $0.00.
- CANNAPHARMARX, INC. repayments of convertible debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. repayments of convertible debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. repayments of convertible debt for the quarter ending 2024-12-31 was -$363.51K.
- CANNAPHARMARX, INC. repayments of convertible debt for fiscal 2024 was $87.77K.
- CANNAPHARMARX, INC. repayments of convertible debt for fiscal 2021 was $53.50K, a 92.41% decline from fiscal 2020.
- CANNAPHARMARX, INC. repayments of convertible debt for fiscal 2020 was $705.00K.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 3 month as first filed | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | -$363.51K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | -$363.51K derived: sum of 3 quarters · filed 2025-08-14 | -$363.51K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-16 | -$363.51K derived: sum of 2 quarters · filed 2025-05-16 | -$363.51K derived: sum of 3 quarters · filed 2025-11-14 | -$296.28K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-12-31 | -$363.51K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | -$363.51K derived: sum of 2 quarters · filed 2025-11-14 | -$296.28K derived: sum of 3 quarters · filed 2025-11-14 | $87.77K 10-K · filed 2025-04-10 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $67.23K derived: sum of 2 quarters · filed 2025-11-14 | $451.28K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $67.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $451.28K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $384.05K 10-Q · filed 2025-05-16 | $451.28K 10-Q · filed 2024-06-25 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-06-25 | ||||
| 2021-12-31 | $53.50K 10-K · filed 2023-09-01 | ||||
| 2020-12-31 | $705.00K 10-K · filed 2022-04-15 |